General Science Current Affairs Analysis
J&J not to enforce patents on TB drug
Bedaquiline is the first drug for tuberculosis, or TB.
It is less toxic and more effective than traditional TB treatments.
Sirturo — its brand name for bedaquiline, which is used in the treatment of multidrug-resistant tuberculosis
Not enforcing the patents provide unfettered access to affordable generic versions of bedaquiline for all people living with drug-resistant tuberculosis who need the drug in low- and middle-income countries.
Delamanid – TB Drug – Japan Company Otsuka
It is another key drug-resistant TB drug used in combination with bedaquiline, and is particularly important for the treatment of children.